Microscopic revelations point to new blood infection therapies

April 4, 2018, University of Calgary
Dr. Bryan Yipp, assistant professor in the Department of Critical Care Medicine at the Cumming School of Medicine and associate director of the Leaders in Medicine program, is investigating the mechanisms of lung pulmonary inflammation. Credit: Riley Brandt, University of Calgary

Researchers at the University of Calgary's Cumming School of Medicine (CSM) have for the first time been able to observe—live and in real-time—how the human body responds to often lethal fungal blood infections in the lung.

In the study, the fungal infection Candida albicans was introduced to mice or human models of the lung vasculature and as blood was pumped over that system, researchers recorded what happened using highly sophisticated microscopes. And what they saw surprised them.

Immune rushed to the scene of the infection, which was expected. But then those cells swarmed, clustered and jammed up the blood vessels causing a potentially dangerous blockage, and that was a revelation, one that could lead to new treatment options for the usually deadly incursions.

This clumping of immune cells was captured in high resolution.

The research study which was led by Dr. Bryan Yipp, assistant professor in the Department of Critical Care Medicine at the Cumming School of Medicine and Tier II Canada Research Chair in Pulmonary Immunology, Inflammation and Host Defence, was recently published in Cell Host & Microbe.

Seeking a greater understanding of lung immune response

Candida albicans is a leading cause of bloodstream infection and fungal sepsis, with a high mortality rate. People with weakened immune systems, such as transplant recipients and patients with genetic deficiencies, are often susceptible to developing the condition. Additionally, those with critical illness requiring intensive care unit (ICU) support are at risk for acquiring a fungal blood infection.

Yipp and his team were interested in understanding how the lung in particular is involved in protecting the body from infections. "For some reason the lung itself has a lot of the main type of immune cell, the neutrophil. We knew this, but the reasons why they are in the lung has remained mysterious," Yipp says.

As well, he says, most research has been on bacterial sepsis but they wanted to focus on fungal sepsis because it is less well understood and fungal infections are growing in number and severity. "Our initial thought was that neutrophils would capture fungi the same as they capture bacteria," Yipp says. "But they became so activated they started to clump and cluster together and actually block the bloodstream."

Advancing diseases-on-chips technology

The research team used sophisticated imaging techniques and novel "disease-on-chips" technology to observe the body's response to fungal blood infections. The chips are about the size of a penny and are intended to mimic an organ system - in this case, lung vasculature.

Cumming School of Medicine researcher Mark Gillrie, now doing postdoc work at MIT, developed the study's high-resolution organs-on-chips.

"We generate a pattern of an organ that we want, creating a 3D hollowed-out structure, stick it on a piece of glass, then we can introduce a lot of different cell types," Gillrie says. Astonishingly, Gillrie says those cells types then have the intrinsic ability to self-organize to a certain degree, into an alveolus in the lung for example, or the blood-brain barrier in the brain.

Seeing is believing

"Our real focus is to visualize how everything actually works," Yipp says, emphasizing the imaging is everything. "These are results we never would have been able to guess at without seeing it."

With a clearer understanding of the disease—and pictures to prove how the human body reacts to a fungal blood infection in the —the researchers say they are looking next to new therapeutic targets.

Yipp says the goal is to find a way to block the clumping of cells without inhibiting the from capturing bugs. And the team has already had some success with anti-inflammatory drugs already on the market for asthma. "We were able to repurpose a drug that has already been approved in humans that could reduce negative consequences of and improve clinical outcomes," Gillrie says.

Explore further: Mice found able to ward off fungal lung infections by causing fungus to kill itself

More information: Esther K.S. Lee et al, Leukotriene B4-Mediated Neutrophil Recruitment Causes Pulmonary Capillaritis during Lethal Fungal Sepsis, Cell Host & Microbe (2017). DOI: 10.1016/j.chom.2017.11.009

Related Stories

Mice found able to ward off fungal lung infections by causing fungus to kill itself

September 8, 2017
(Medical Xpress)—A team of researchers from the U.S., Germany and Israel has found that mice are able to ward off fungal lung infections because their immune systems cause fungal spores to die. In their paper published ...

A step towards a new drug to treat fungal infections that kill 1.6 million people annually

October 10, 2017
A team from Sydney's Westmead Institute for Medical Research is a step closer to developing a drug to treat life-threatening fungal infections that cause more than 1.6 million deaths annually.

New insight into body's response to killer fungus

March 1, 2018
Scientists at the University of Aberdeen have made a new discovery that could help in the fight against a fungus that kills around 200,000 people every year and causes lung and allergic diseases in millions of others.

Molecular causes for life-threatening fungal infections in case of sepsis unravelled

July 27, 2012
(Medical Xpress) -- Pathogenic fungi cause infections with a high mortality rate in patients with weakened immune systems. At Karl Kuchler’s CD Laboratory at the MedUni Vienna, the molecular causes of the life-threatening ...

Cells that die with a bang contribute to high death rate in bloodstream infections

October 10, 2017
Cells lining blood vessels in the lungs that are exposed to bacterial toxins don't die easy, according to a new study led by researchers at the University of Illinois at Chicago College of Medicine.

Recommended for you

Evidence that addictive behaviors have strong links with ancient retroviral infection

September 24, 2018
New research from an international team led by Oxford University's Department of Zoology and the National-Kapodistrian University of Athens, published today in Proceedings of the National Academy of Sciences (PNAS), shows ...

Taking a catnap? Mouse mutation shown to increase need for sleep

September 24, 2018
Sleep is vital for adequate functioning across the animal kingdom, but little is known about the physiological mechanisms that regulate it, or the reasons for natural variation in people's sleep patterns.

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Know someone sick? Your own smell might give it away

September 24, 2018
Odors surround us, providing cues about many aspects of personal identity, including health status. Now, research from the Monell Center extends the scope and significance of personal odors as a source of information about ...

Reconstructing healthy liver cells using a nanomaterial-based matrix 

September 24, 2018
NUS pharmaceutical scientists, together with clinicians from the National University Health System (NUHS), have developed a nanomaterial-based hydrogel that encourages amniotic epithelial cells (a type of stem cell) to grow ...

Japanese team creates human oogonia using human stem cells in artificial mouse ovaries

September 21, 2018
A team of researchers with members from several institutions in Japan has successfully generated human oogonia inside of artificial mouse ovaries using human stem cells. In their paper published in the journal Science, the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.